银屑病患者首发与复发性抑郁的风险:一项基于人群的队列研究
该研究利用丹麦行政登记数据,将1997年1月1日至2016年12月31日期间年龄≥18岁的银屑病患者与无银屑病个体按1:1匹配,计算抑郁发病率并采用Cox回归估计调整风险比。共纳入247755例银屑病患者(轻度220721例、中度24771例、重度2263例)及同等数量对照,随访最长20年,银屑病患者中45641例、对照中36299例发生抑郁;轻、中、重度银屑病调整HR分别为1.19(95%CI 1.17-1.20)、1.19(95%CI 1.15-1.23)和1.50(95%CI 1.23-1.84)。结论认为银屑病与抑郁风险独立相关,结果可能有助于临床医生识别高危个体。
要点
- 轻、中、重度银屑病抑郁调整HR分别为1.19、1.19和1.50,重度风险最高。
- 重度银屑病患者中40-50岁年龄组抑郁风险最高。
- 合并炎症性肠病(而非银屑病关节炎)与抑郁风险增加相关;既往抑郁者抑郁发病率明显更高。
核心结论
- 银屑病与抑郁风险独立相关,这些结果可能有助于临床医生识别特别高风险的个体。
研究设计与样本
- 基于丹麦行政登记数据的个体层面链接,采用基于人群的队列研究设计。
- 1997年1月1日至2016年12月31日期间年龄≥18岁的银屑病患者按1:1与无银屑病个体匹配。
- 共纳入247755例银屑病患者:轻度(外用治疗)220721例、中度(系统性非生物制剂)24771例、重度(生物制剂)2263例,以及同等数量匹配对照。
- 计算发病率,并通过Cox回归估计调整风险比(HR)。
主要发现
- 随访最长20年,银屑病患者中45641例、对照中36299例发生抑郁。
- 调整模型中,轻度、中度和重度银屑病抑郁的HR(95%CI)分别为1.19(1.17-1.20)、1.19(1.15-1.23)和1.50(1.23-1.84)。
- 重度银屑病患者中40-50岁年龄组观察到的风险最高。
- 合并炎症性肠病(而非银屑病关节炎)与抑郁风险增加相关。
- 既往有抑郁的患者中抑郁发病率明显更高。
关键数值与推荐
- 轻度银屑病(外用治疗)抑郁调整HR为1.19(95%CI 1.17-1.20)。
- 中度银屑病(系统性非生物制剂)抑郁调整HR为1.19(95%CI 1.15-1.23)。
- 重度银屑病(生物制剂)抑郁调整HR为1.50(95%CI 1.23-1.84)。
临床怎么用
- 原文结论指出这些结果可能有助于临床医生识别特别高风险的个体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis impairs quality of life, but it is unknown whether psoriasis is also an independent risk factor for depression. OBJECTIVES: To evaluate the incidence and risk of new and recurrent depression in patients with psoriasis. METHODS: We used individual-level linkage of Danish administrative registers. Patients with psoriasis aged ≥ 18 years between 1 January 1997 and 31 December 2016 were matched 1 : 1 with individuals without psoriasis. Incidence rates were calculated and adjusted hazard ratios (HRs) estimated by Cox regression. RESULTS: There were 247 755 patients with psoriasis: 220 721 were treated with topicals (mild psoriasis), 24 771 with systemic nonbiologics (moderate psoriasis) and 2263 with biological therapy (severe psoriasis). The same number of matched referents without psoriasis were also analysed. During a maximum 20 years of follow-up, 45 641 patients with psoriasis and 36 299 referents developed depression. In adjusted models, the HRs (95% confidence interval) of depression were 1·19 (1·17-1·20), 1·19 (1·15-1·23) and 1·50 (1·23-1·84) for mild, moderate and severe psoriasis, respectively. The highest risk was observed among patients with severe psoriasis aged 40-50 years. Concurrent inflammatory bowel disease, but not psoriatic arthritis, was associated with increased risk of depression. The incidence of depression was markedly higher among patients with previous depression. CONCLUSIONS: Psoriasis was independently associated with risk of depression. These results may help clinicians identify particularly high-risk individuals.
引用
- Egeberg A, Thyssen JP, Wu JJ, et al. Risk of first-time and recurrent depression in patients with psoriasis: a population-based cohort study. Br J Dermatol. 2018. PMID: 30229872. doi:10.1111/bjd.17208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。